Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
Resource Type
Article
Authors
Wildman, Eden ; Rampling, Tommy ; Morris, Sheila ; Shoemaker, Kathryn ; Aksyuk, Anastasia ; Padilla, Marcelino Giune ; Roe, Tiffany ; Petropoulos, Christos J ; Wrin, Terri ; Colton, Hayley ; Bisnauthsing, Karen ; Smith, Catherine ; Leeman, Lucy ; Galloway, James ; Nagra, Deepak ; Lazarus, Rajeka ; Penciu, Florentina ; Hunter, Ewan ; Sahdev, Anju ; Turner, David ; Royal, Simon ; Uriel, Alison ; Ustianowski, Andrew ; Moran, Ed ; Green, Christopher ; Desai, Amisha ; Lakeman, Nicki ; Moore, Patrick ; Whittington, Ashley ; Kobielusz Gembala, Iwona ; Konieczny, Marek ; Ramasamy, Maheshi N ; Kelly, Elizabeth J ; Seegobin, Seth ; Dargan, Paul I ; Payne, Ruth ; Libri, Vincenzo ; Adam, Matthew ; Aley, Parvinder K ; Martinez-Alier, Nuria ; Church, Alison ; Jepson, Brett ; Khan, Mark ; Matthews, Sam ; Townsend, G Todd ; Vekemans, Johan ; Bibi, Sagida ; Swanson, Phillip A, II ; Lambe, Teresa ; Pangalos, Menelas N ; Villafana, Tonya ; Pollard, Andrew J ; Green, Justin A
Source
In The Lancet Microbe November 2023 4(11):e863-e874
Subject
Primary Research Articles
Language
ISSN
2666-5247